Aytu BioPharma
(NASDAQ) AYTU
Aytu BioPharma Financials at a Glance
Market Cap
$28.77M
Revenue (TTM)
$62.64M
Net Income (TTM)
$24.44M
EPS (TTM)
$-3.84
P/E Ratio
-0.70
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$2.69
Volume
2,237
Open
$2.62
Price
$2.69
Volume
2,237
Open
$2.62
Previous Close
$2.69
Daily Range
$2.62 - $2.69
52-Week Range
$0.95 - $3.06
Dividend
$0.00
Beta (Volatility)
0.92 (Low)
Price
$2.69
Volume
2,237
Open
$2.62
Previous Close
$2.69
Daily Range
$2.62 - $2.69
52-Week Range
$0.95 - $3.06
AYTU News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aytu BioPharma
Industry
Pharmaceuticals
Sector
Health CareEmployees
83
CEO
Joshua R. Disbrow, MBA
Website
www.aytubio.comHeadquarters
Englewood, CO 80112, US
AYTU Financials
Key Financial Metrics (TTM)
Gross Margin
66%
Operating Margin
-14%
Net Income Margin
-39%
Return on Equity
-109%
Return on Capital
-15%
Return on Assets
-20%
Earnings Yield
-1.43%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$28.77M
Shares Outstanding
10.73M
Volume
2.24K
Short Interest
0.00%
Avg. Volume
75.04K
Financials (TTM)
Gross Profit
$45.83M
Operating Income
$7.83M
EBITDA
$4.67M
Operating Cash Flow
$1.94M
Capital Expenditure
$3.23M
Free Cash Flow
$5.17M
Cash & ST Invst.
$30.95M
Total Debt
$22.94M
Aytu BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.16M
-6.5%
Gross Profit
$9.10M
-15.6%
Gross Margin
59.99%
N/A
Market Cap
$28.77M
N/A
Market Cap/Employee
$282.01K
N/A
Employees
102
N/A
Net Income
$10.58M
-1443.1%
EBITDA
$9.14M
-447.0%
Quarterly Fundamentals
Net Cash
$6.95M
+113.4%
Accounts Receivable
$30.92M
+21.7%
Inventory
$8.66M
-21.9%
Long Term Debt
$11.94M
+7.7%
Short Term Debt
$11.13M
+83.9%
Return on Assets
-20.04%
N/A
Return on Invested Capital
-15.37%
N/A
Free Cash Flow
$3.66M
+26.2%
Operating Cash Flow
$3.67M
+26.5%